A comparative study of clinicopathological significance, FGFBP1, and WISP-2 expression between squamous cell/adenosquamous carcinomas and adenocarcinoma of the gallbladder

Int J Clin Oncol. 2014 Apr;19(2):325-35. doi: 10.1007/s10147-013-0550-9. Epub 2013 Apr 17.

Abstract

Background: The differences in clinical, pathological, and biological characteristics between adenocarcinoma (AC) and squamous cell/adenosquamous carcinoma (SC/ASC) of gallbladder cancer have not been well documented. This study is to compare the clinicopathological characteristics and FGFBP1 and WISP-2 expression between AC and SC/ASC patients.

Methods: We examined FGFBP1 and WISP-2 expression in 46 SC/ASC and 80 AC samples using immunohistochemistry and analyzed their correlations with clinicopathological characteristics.

Results: SC/ASCs occur more frequently in older patients and often correspond to larger tumor masses than ACs. Positive FGFBP1 and negative WISP-2 expression were significantly associated with lymph node metastasis and invasion of SC/ASCs and ACs. In addition, positive FGFBP1 and negative WISP-2 expression were significantly associated with differentiation and TMN stage in ACs. Univariate Kaplan-Meier analysis showed that either elevated FGFBP1 (p < 0.001) or lowered WISP-2 (p < 0.001) expression was closely associated with decreased overall survival in both SC/ASC and AC patients. Multivariate Cox regression analysis showed that positive FGFBP1 expression (p = 0.001) or negative WISP-2 expression (p = 0.035 for SC/ASC and p = 0.009 for AC) is an independent predictor of poor prognosis in both SC/ASC and AC patients. We also revealed that differentiation, tumor size, TNM stage, lymph node metastasis, invasion, and surgical procedure were associated with survival of both SC/ASC and AC patients.

Conclusion: Our study suggested that the overexpression of FGFBP1 or loss of WISP-2 expression is closely related to the metastasis, invasion and poor prognosis of gallbladder cancer.

Publication types

  • Comparative Study

MeSH terms

  • Adenocarcinoma / chemistry
  • Adenocarcinoma / mortality
  • Adenocarcinoma / pathology*
  • Adult
  • Aged
  • Aged, 80 and over
  • CCN Intercellular Signaling Proteins / analysis*
  • CCN Intercellular Signaling Proteins / physiology
  • Carcinoma, Adenosquamous / chemistry
  • Carcinoma, Adenosquamous / mortality
  • Carcinoma, Adenosquamous / pathology*
  • Carcinoma, Squamous Cell / chemistry
  • Carcinoma, Squamous Cell / mortality
  • Carcinoma, Squamous Cell / pathology*
  • Carrier Proteins / analysis*
  • Carrier Proteins / physiology
  • Female
  • Gallbladder Neoplasms / chemistry
  • Gallbladder Neoplasms / mortality
  • Gallbladder Neoplasms / pathology*
  • Humans
  • Immunohistochemistry
  • Intercellular Signaling Peptides and Proteins / analysis*
  • Intercellular Signaling Peptides and Proteins / physiology
  • Male
  • Middle Aged
  • Neoplasm Staging
  • Proportional Hazards Models
  • Repressor Proteins / analysis*
  • Repressor Proteins / physiology

Substances

  • CCN Intercellular Signaling Proteins
  • CCN5 protein, human
  • Carrier Proteins
  • Intercellular Signaling Peptides and Proteins
  • Repressor Proteins
  • FGFBP1 protein, human